dostarlimab
gsk
['rectal', 'dostarlimab']
the 3 rd #asco22 mismatch repair deficient,locally advanced #rectalcancer is highly sensitive to single-agent pd1 blockade 1 2 completed tx w/dostarlimab 6 mo followup
all1 2 :clinical complete response
new standard for msi high 
Clinical Oncologist from Texas????Director of @OncoAlert ?? Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own??